Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Everard, Amandine ^a   Geurts, Lucie ^a   van Roye, Marie ^a   Delzenne, Nathalie M ^a   Cani, Patrice D ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; META 060; OCCLUDIN; PROTEIN ZO1; TETRAHYDRO ISO ALPHA ACID DERIVATIVE; UNCLASSIFIED DRUG; ALKALINE PHOSPHATASE; CYCLOPENTANE DERIVATIVE; GLUCOSE; MEMBRANE PROTEIN; PHOSPHOPROTEIN; PLANT EXTRACT; ZONULA OCCLUDENS-1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; BODY FAT; CONTROLLED STUDY; ENDOTOXEMIA; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HOPS; HYPERINSULINEMIA; INSULIN SENSITIVITY; INTESTINE MUCOSA PERMEABILITY; LIPID DIET; METABOLIC ENDOTOXEMIA; MOUSE; NONHUMAN; OBESITY; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG EFFECT; HUMULUS; HYPERINSULINISM; INSULIN RESISTANCE; METABOLISM; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; WEIGHT GAIN;

HUMULUS; HUMULUS LUPULUS; MUS; RODENTIA;

ALKALINE PHOSPHATASE; ANIMALS; CYCLOPENTANES; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; ENDOTOXEMIA; GLUCOSE; GLUCOSE INTOLERANCE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMULUS; HYPERINSULINISM; INSULIN RESISTANCE; INTERLEUKIN-10; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PHOSPHOPROTEINS; PLANT EXTRACTS; WEIGHT GAIN;

EID: 84859027218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033858     Document Type: Article

References (42)

1. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
2. Olefsky JM, Glass CK, (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72: 219-246.
3. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
4. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
5. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GM, et al. (2011) Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60: 2775-2786.
6. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383.
7. Cani PD, Possemiers S, Van de WT, Guiot Y, Everard A, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
8. Muccioli GG, Naslain D, Backhed F, Reigstad CS, Lambert DM, et al. (2010) The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 6: 392.
9. Cani PD, Delzenne NM, (2011) The gut microbiome as therapeutic target. Pharmacol Ther 130: 202-212.
10. De La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, et al. (2010) Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299: G440-G448.
11. Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292: G518-G525.
12. Basu S, Haghiac M, Surace P, Challier JC, Guerre-Millo M, et al. (2011) Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 19: 476-482.
13. Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V, (2011) Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34: 392-397.
14. Zanoli P, Zavatti M, (2008) Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol 116: 383-396.
15. Desai A, Konda VR, Darland G, Austin M, Prabhu KS, et al. (2009) META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS-mediated inflammation in vitro and ex vivo. Inflamm Res 58: 229-234.
16. Konda VR, Desai A, Darland G, Bland JS, Tripp ML, (2010) META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis. Arthritis Rheum 62: 1683-1692.
17. Van CM, Heyerick A, Libert C, Swerts K, Philippe J, et al. (2009) Hop bitter acids efficiently block inflammation independent of GRalpha, PPARalpha, or PPARgamma. Mol Nutr Food Res 53: 1143-1155.
18. Minich DM, Lerman RH, Darland G, Babish JG, Pacioretty LM, et al. (2010) Hop and Acacia Phytochemicals Decreased Lipotoxicity in 3T3-L1 Adipocytes, db/db Mice, and Individuals with Metabolic Syndrome. J Nutr Metab 2010.
19. Yajima H, Ikeshima E, Shiraki M, Kanaya T, Fujiwara D, et al. (2004) Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance. J Biol Chem 279: 33456-33462.
20. Yajima H, Noguchi T, Ikeshima E, Shiraki M, Kanaya T, et al. (2005) Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents. Int J Obes (Lond) 29: 991-997.
21. Geurts L, Everard A, le RP, Delzenne NM, Cani PD, (2012) Ripened Dairy Products Differentially Affect Hepatic Lipid Content and Adipose Tissue Oxidative Stress Markers in Obese and Type 2 Diabetic Mice. J Agric Food Chem DOI: 10.1021/jf204916x.
22. BESSEY OA, LOWRY OH, BROCK MJ, (1946) A method for the rapid determination of alkaline phosphates with five cubic millimeters of serum. J Biol Chem 164: 321-329.
23. Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, et al. (2009) Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 58: 2525-2535.
24. Straczkowski M, Kowalska I, Nikolajuk A, Krukowska A, Gorska M, (2005) Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals. Diabetes Care 28: 2036-2037.
25. Hall D, Poussin C, Velagapudi VR, Empsen C, Joffraud M, et al. (2010) Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state. J Biol Chem 285: 31011-31023.
26. Eyles JL, Roberts AW, Metcalf D, Wicks IP, (2006) Granulocyte colony-stimulating factor and neutrophils-forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol 2: 500-510.
27. Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, et al. (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care 32: 2281-2287.
28. Deopurkar R, Ghanim H, Friedman J, Abuaysheh S, Sia CL, et al. (2010) Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 33: 991-997.
29. Vaishnava S, Hooper LV, (2007) Alkaline phosphatase: keeping the peace at the gut epithelial surface. Cell Host Microbe 2: 365-367.
30. Bates JM, Akerlund J, Mittge E, Guillemin K, (2007) Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2: 371-382.
31. Lalles JP, (2010) Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 68: 323-332.
32. Hall AJ, Babish JG, Darland GK, Carroll BJ, Konda VR, et al. (2008) Safety, efficacy and anti-inflammatory activity of rho iso-alpha-acids from hops. Phytochemistry 69: 1534-1547.
33. Hotamisligil GS, Shargill NS, Spiegelman BM, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
34. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, et al. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271: 665-668.
35. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, et al. (2005) Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54: 2939-2945.
36. Nusrat A, Turner JR, Madara JL, (2000) Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279: G851-G857.
37. Gonzalez-Mariscal L, Tapia R, Chamorro D, (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778: 729-756.
38. Moroi S, Saitou M, Fujimoto K, Sakakibara A, Furuse M, et al. (1998) Occludin is concentrated at tight junctions of mouse/rat but not human/guinea pig Sertoli cells in testes. Am J Physiol 274: C1708-C1717.
39. Al-Sadi R, Ye D, Said HM, Ma TY, (2010) IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway. Am J Pathol 177: 2310-2322.
40. Al-Sadi R, Ye D, Said HM, Ma TY, (2011) Cellular and molecular mechanism of interleukin-1beta modulation of Caco-2 intestinal epithelial tight junction barrier. J Cell Mol Med 15: 970-982.
41. Kimura H, Sawada N, Tobioka H, Isomura H, Kokai Y, et al. (1997) Bacterial lipopolysaccharide reduced intestinal barrier function and altered localization of 7H6 antigen in IEC-6 rat intestinal crypt cells. J Cell Physiol 171: 284-290.
42. Sheth P, Delos SN, Seth A, LaRusso NF, Rao RK, (2007) Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 293: G308-G318.